zalcitabine has been researched along with Disease Models, Animal in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.69) | 18.7374 |
| 1990's | 4 (10.26) | 18.2507 |
| 2000's | 13 (33.33) | 29.6817 |
| 2010's | 16 (41.03) | 24.3611 |
| 2020's | 3 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Aly, E; Khajah, MA; Masocha, W | 1 |
| Galeotti, N; Herdegen, T; Manassero, G; Sanna, MD; Vercelli, A | 1 |
| Allegue, C; Brea, J; Burgueño, J; Carracedo, Á; Cimadevila, M; Cruz, R; Domínguez, E; Loza, MI; Martínez, AL; Merlos, M; Monroy, X; Varela, MJ | 1 |
| Hu, D; Mao, S; Nie, S; Niu, J; Wang, T; Xiong, J; Zeng, F; Zhang, Z | 1 |
| Masocha, W; Thomas, A | 1 |
| Lau, T; Rice, AS; Smith, MT; Wallace, VC; Wyse, BD | 1 |
| Galeotti, N; Ghelardini, C; Quattrone, A; Sanna, MD | 1 |
| Galeotti, N; Ghelardini, C; Mello, T; Quattrone, A; Sanna, MD | 1 |
| Candiotti, KA; Hao, S; Huang, W; Levitt, RC; Liu, S; Lubarsky, DA; Zheng, W | 1 |
| Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD | 1 |
| Candiotti, KA; Hao, S; Huang, W; Kanao, M; Kanda, H; Levitt, RC; Liu, S; Lubarsky, DA; Yi, H | 1 |
| Garcia-Perez, E; Serra, J; Solà, R; Sumalla, M | 1 |
| Hao, S; Huang, W; Iida, T; Kanda, H; Liu, S; Lubarsky, DA; Yi, H | 1 |
| Galeotti, N; Ghelardini, C; Mello, T; Peroni, D; Quattrone, A; Sanna, MD | 1 |
| Blackbeard, J; Dickenson, AH; Hasnie, FS; Hosseini, R; Jina, N; Maratou, K; McMahon, SB; Okuse, K; Orengo, C; Pheby, T; Rice, AS; Wallace, VC | 1 |
| French, JE; Karlsson, A; Rasmussen, A; Söderkvist, P; Ungerbäck, J | 1 |
| Gordon, YJ; Romanowski, EG; Yates, KA | 1 |
| Ferrari, LF; Levine, JD | 1 |
| Bogen, O; Chum, A; Ferrari, LF; Levine, JD; Reichling, DB | 1 |
| Blackbeard, J; Field, MJ; Hasnie, F; O'Dea, KP; Pheby, T; Rice, AS; Segerdahl, A; Takata, M; Wallace, VC | 1 |
| Berthillon, P; Cheng, YC; Germon, S; Guerhier, FL; Pichoud, C; Seigneres, B; Trepo, C; Zoulim, F | 1 |
| Bullock, B; Carruth, LM; Clements, JE; Gama, L; Li, M; Mankowski, JL; Zink, MC | 1 |
| Joseph, EK; Levine, JD | 1 |
| Bhangoo, SK; Chan, DM; McGinnis, C; Miller, RJ; Ren, D; Ripsch, MS; Weiss, C; White, FA | 1 |
| Chen, X; Levine, JD | 1 |
| Borjabad, A; Chao, W; Hadas, E; Ichiyama, K; Potash, MJ; Saini, M; Volsky, DJ | 1 |
| Dandekar, S; Sankaran, S; Verhoeven, D | 1 |
| Blackbeard, J; Hasnie, F; McMahon, SB; Pheby, T; Rice, AS; Segerdahl, AR; Wallace, VC | 1 |
| Simpson, DM; Tagliati, M | 1 |
| Brandi, G; Chiarantini, L; Fraternale, A; Magnani, M; Rossi, L; Schiavano, GF | 1 |
| Gaubert, G; Gosselin, G; Maury, G; Salvatori, D; Vincenzetti, S; Vita, A | 1 |
| Anderson, TD; Arceo, R; Arezzo, J; Brosnan, C; Davidovich, A; Schaumburg, H | 1 |
| Basham, T; Holdener, T; Merigan, T | 1 |
| Hill, DL; Hoover, EA; Mullins, JI; Perigo, NA; Quackenbush, SL; Strobel, JD; Zeidner, NS | 1 |
| de Noronha, F; Postie, L; Roneker, C; Tavares, L | 1 |
| Hill, DL; Hoover, EA; Mullins, JI; Perigo, NA; Strobel, JD; Zeidner, NS | 1 |
2 review(s) available for zalcitabine and Disease Models, Animal
| Article | Year |
|---|---|
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
Topics: Animals; Didanosine; Dideoxynucleosides; Disease Models, Animal; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine; Zalcitabine | 1995 |
Antiretroviral agents.
Topics: Acyclovir; Animals; Antiviral Agents; Carcinogens; Didanosine; Disease Models, Animal; Evidence-Based Medicine; Humans; Intestinal Absorption; Neoplasms; Risk Factors; Tissue Distribution; Zalcitabine; Zidovudine | 2000 |
37 other study(ies) available for zalcitabine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Topics: Animals; Brain; Disease Models, Animal; Female; Humans; Hyperalgesia; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neuralgia; Polycyclic Sesquiterpenes; Receptor, Cannabinoid, CB2; Reverse Transcriptase Inhibitors; Skin; Zalcitabine | 2019 |
The isoform-specific functions of the c-Jun N-terminal kinase (JNK) in a mouse model of antiretroviral-induced painful peripheral neuropathy.
Topics: Animals; Anti-Retroviral Agents; Disease Models, Animal; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Mice, Knockout; Pain; Peripheral Nervous System Diseases; Zalcitabine | 2020 |
Identification of Novel Regulators of Zalcitabine-Induced Neuropathic Pain.
Topics: Animals; Calcium Signaling; Disease Models, Animal; Ganglia, Spinal; Humans; Hyperalgesia; Neuralgia; Quality of Life; Sensory Receptor Cells; Zalcitabine | 2021 |
2',3'-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Cells, Cultured; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Mice; Neuroprotective Agents; Substantia Nigra; Zalcitabine | 2017 |
Indomethacin plus minocycline coadministration relieves chemotherapy and antiretroviral drug-induced neuropathic pain in a cannabinoid receptors-dependent manner.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Retroviral Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Female; Indomethacin; Mice, Inbred BALB C; Minocycline; Neuralgia; Paclitaxel; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Zalcitabine | 2019 |
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy.
Topics: Analgesics; Angiotensin II Type 2 Receptor Blockers; Animals; Anti-HIV Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Hot Temperature; Hyperalgesia; Imidazoles; Male; Neuralgia; Polyneuropathies; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sciatic Neuropathy; Time Factors; Touch; Zalcitabine | 2014 |
PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy.
Topics: Animals; Anti-HIV Agents; Brain; Disease Models, Animal; ELAV Proteins; ELAV-Like Protein 4; GAP-43 Protein; Hyperalgesia; Male; Mice; Pain; Peripheral Nervous System Diseases; Protein Kinase C; Reverse Transcriptase Inhibitors; Zalcitabine | 2014 |
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Topics: Animals; Anti-Retroviral Agents; Cells, Cultured; Disease Models, Animal; ELAV Proteins; GAP-43 Protein; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neurons; Oligodeoxyribonucleotides, Antisense; Pain; Peripheral Nervous System Diseases; Phosphopyruvate Hydratase; Protein Kinase C; Spinal Cord; Time Factors; Zalcitabine | 2014 |
IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats.
Topics: Animals; Antiviral Agents; Chemokine CXCL12; Disease Models, Animal; Ganglia, Spinal; Genetic Vectors; HIV Envelope Protein gp120; Interleukin-10; Male; Neuralgia; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; Simplexvirus; Spinal Cord Dorsal Horn; Time Factors; Tumor Necrosis Factor-alpha; Zalcitabine | 2014 |
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine | 2015 |
Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.
Topics: Animals; CCAAT-Enhancer-Binding Protein-beta; Cyclic AMP Response Element-Binding Protein; Decarboxylation; Disease Models, Animal; gamma-Aminobutyric Acid; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glutamate Decarboxylase; Glutamic Acid; HIV Envelope Protein gp120; HIV Infections; Humans; Male; Mitochondria; Pain Threshold; Phosphorylation; Rats, Sprague-Dawley; Sciatic Nerve; Sciatica; Simplexvirus; Spinal Cord Dorsal Horn; Superoxides; Time Factors; Zalcitabine | 2015 |
Behavioral and electrophysiological abnormalities in two rat models of antiretroviral drug-induced neuropathy.
Topics: Action Potentials; Animals; Anti-HIV Agents; Disease Models, Animal; Male; Nerve Fibers, Unmyelinated; Neural Conduction; Neurophysiology; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stavudine; Zalcitabine | 2015 |
Spinal CPEB-mtROS-CBP signaling pathway contributes to perineural HIV gp120 with ddC-related neuropathic pain in rats.
Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Gene Expression Regulation; HIV Envelope Protein gp120; Humans; Hyperalgesia; Male; Membrane Proteins; mRNA Cleavage and Polyadenylation Factors; Neuralgia; Oligodeoxyribonucleotides, Antisense; Pain Management; Pain Threshold; Phosphoproteins; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Spinal Cord; Succinate Dehydrogenase; Transcription Factors; Zalcitabine | 2016 |
Increase of neurofilament-H protein in sensory neurons in antiretroviral neuropathy: Evidence for a neuroprotective response mediated by the RNA-binding protein HuD.
Topics: Animals; Anti-Retroviral Agents; Antibodies; Brain-Derived Neurotrophic Factor; Disease Models, Animal; ELAV-Like Protein 4; Ganglia, Spinal; Gene Silencing; Male; Mice; Neurofilament Proteins; Neuroprotective Agents; Oligonucleotides, Antisense; Protein Kinase C; RNA, Messenger; Sciatic Nerve; Sciatic Neuropathy; Sensory Receptor Cells; Signal Transduction; Spinal Cord; Up-Regulation; Zalcitabine | 2016 |
Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain.
Topics: Animals; Denervation; Disease Models, Animal; Ganglia, Spinal; Gene Expression Regulation; HIV Envelope Protein gp120; HIV Infections; Male; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; RNA, Messenger; Sensory Receptor Cells; Spinal Nerves; Transfection; Zalcitabine | 2009 |
Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
Topics: Amino Acid Sequence; Animals; Butadienes; Disease Models, Animal; Lymphoma; Mice; Molecular Sequence Data; Mutation; Receptor, Notch1; Sequence Alignment; Zalcitabine | 2008 |
The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cytosine; Disease Models, Animal; Female; Humans; Organophosphonates; Rabbits; Tumor Cells, Cultured; Viral Plaque Assay; Virus Replication; Zalcitabine | 2009 |
Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.
Topics: Alcoholic Neuropathy; Animals; Anti-HIV Agents; Disease Models, Animal; Drug Interactions; Electron Transport Chain Complex Proteins; Ethanol; Hyperalgesia; Male; Mitochondria; Oligodeoxyribonucleotides, Antisense; Peripheral Nervous System Diseases; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Zalcitabine | 2010 |
Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.
Topics: Analysis of Variance; Animals; Anti-HIV Agents; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dynamins; Epinephrine; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Hydrogen Peroxide; Hyperalgesia; Male; Nerve Growth Factor; Neuralgia; Nitric Oxide Donors; Nitro Compounds; Oligodeoxyribonucleotides, Antisense; Organoplatinum Compounds; Oxaliplatin; Pain Measurement; Quinazolinones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Zalcitabine | 2011 |
The correlation between pain-related behaviour and spinal microgliosis in four distinct models of peripheral neuropathy.
Topics: Animals; Anti-HIV Agents; Behavior, Animal; Disease Models, Animal; Flow Cytometry; Gliosis; Herpes Zoster; Herpesvirus 3, Human; HIV Envelope Protein gp120; HIV Infections; Hyperalgesia; Immunohistochemistry; Male; Microglia; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Spinal Cord; Spinal Nerves; Zalcitabine | 2012 |
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Topics: Animals; Disease Models, Animal; Ducks; Hepadnaviridae Infections; Hepatitis; Hepatitis B Virus, Duck; Hepatitis B Virus, Woodchuck; Hepatitis, Viral, Animal; Humans; In Vitro Techniques; Marmota; Reverse Transcriptase Inhibitors; RNA, Viral; Virus Replication; Zalcitabine | 2002 |
The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy.
Topics: Adenine; Animals; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Histocompatibility Antigens Class II; Injections, Subcutaneous; Macaca nemestrina; Organophosphonates; Polymerase Chain Reaction; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Time Factors; Zalcitabine | 2005 |
Mitochondrial electron transport in models of neuropathic and inflammatory pain.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antimycin A; Disease Models, Animal; Drug Interactions; Electron Transport; Enzyme Inhibitors; Hyperalgesia; Male; Mitochondria; Multienzyme Complexes; Neuralgia; Neurogenic Inflammation; Pain Measurement; Pain Threshold; Peripheral Nerves; Rats; Rats, Sprague-Dawley; Rotenone; Streptozocin; Time Factors; Uncoupling Agents; Vincristine; Zalcitabine | 2006 |
CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.
Topics: Analysis of Variance; Animals; Chemokine CXCL12; Chemokines, CXC; Disease Models, Animal; Female; Ganglia, Spinal; Gene Expression Regulation; Neuralgia; Neuroglia; Neurons; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Reverse Transcriptase Inhibitors; RNA, Messenger; Schwann Cells; Sciatic Nerve; Statistics, Nonparametric; Zalcitabine | 2007 |
Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
Topics: Acquired Immunodeficiency Syndrome; Alcoholic Neuropathy; Animals; Comorbidity; Disease Models, Animal; Ethanol; Mechanics; Mechanotransduction, Cellular; Nerve Fibers, Unmyelinated; Pain; Peripheral Nervous System Diseases; Rats; Zalcitabine | 2007 |
Testing antiretroviral drug efficacy in conventional mice infected with chimeric HIV-1.
Topics: Animals; Anti-HIV Agents; Chimera; Dideoxynucleosides; Disease Models, Animal; DNA, Viral; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Macrophages, Peritoneal; Mice; Polymerase Chain Reaction; Spleen; Viral Load; Zalcitabine | 2007 |
Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy.
Topics: Adenine; Animals; Anti-Retroviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; DNA, Viral; Emtricitabine; Flow Cytometry; Immunologic Memory; Lymphoid Tissue; Macaca mulatta; Organophosphonates; Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocyte Subsets; Tenofovir; Viral Load; Virus Replication; Zalcitabine | 2007 |
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.
Topics: Animals; Anti-Bacterial Agents; Anti-HIV Agents; Chemokine CCL2; Cold Temperature; Disease Models, Animal; Epidermis; Ganglia, Spinal; Gliosis; HIV Envelope Protein gp120; Hot Temperature; Hyperalgesia; Male; Minocycline; Motor Activity; Nerve Fibers; Nerve Tissue Proteins; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Zalcitabine | 2007 |
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate.
Topics: Administration, Oral; Animals; Antiviral Agents; Body Weight; Deoxycytosine Nucleotides; Dideoxynucleotides; Disease Models, Animal; Drug Carriers; Erythrocytes; Female; Gene Products, gag; Immunoblotting; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Lactates; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Retroviridae; Spleen; Zalcitabine | 1993 |
Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs.
Topics: Animals; Anti-HIV Agents; Cells, Cultured; Cytidine; Cytopathogenic Effect, Viral; Disease Models, Animal; Dose-Response Relationship, Drug; Sheep; Viral Load; Virus Replication; Visna-maedi virus; Zalcitabine | 2001 |
Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.
Topics: Administration, Oral; Animals; Axons; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Female; Male; Myelin Sheath; Neural Conduction; Paresis; Peripheral Nerves; Peripheral Nervous System Diseases; Rabbits; Sciatic Nerve; Zalcitabine | 1992 |
Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Therapy, Combination; Female; HIV Infections; Mice; Mice, Inbred C57BL; Zalcitabine; Zidovudine | 1991 |
Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cats; Cell Line; Cytopathogenic Effect, Viral; Delayed-Action Preparations; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Implants; Drug Therapy, Combination; Immunologic Deficiency Syndromes; Injections, Intravenous; Injections, Subcutaneous; Leukemia Virus, Feline; Leukemia, Experimental; Retroviridae Infections; Specific Pathogen-Free Organisms; Tetrahydrouridine; Viremia; Zalcitabine | 1989 |
Testing of nucleoside analogues in cats infected with feline leukemia virus: a model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Viral; Antiviral Agents; Cats; Cell Line; Didanosine; Dideoxyadenosine; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Immunologic Deficiency Syndromes; Leukemia Virus, Feline; Leukemia, Experimental; Nucleosides; Specific Pathogen-Free Organisms; Virus Replication; Zalcitabine; Zidovudine | 1989 |
Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Monoclonal; Capsules; Cats; Dideoxynucleosides; Disease Models, Animal; Drug Implants; Drug Therapy, Combination; Gene Products, gag; Immunologic Deficiency Syndromes; Infusions, Intravenous; Injections, Subcutaneous; Interferon Type I; Leukemia Virus, Feline; Retroviridae Proteins; Tetrahydrouridine; Tumor Necrosis Factor-alpha; Virus Replication; Zalcitabine | 1989 |